Nevanac (nepafenac) / Novartis |
2011-006066-40: The post-cataract inflammatory reaction with combination therapy of topical steroid and NSAID. ble |
|
|
| Ongoing | 4 | 10 | Europe | Eye drops, suspension, NEVANAC | The Rotterdam Eye Hospital, Nuts OHRA | Ocular inflammatory reaction after cataract surgery., Ocular inflammatory reaction after cataract surgery., Body processes [G] - Immune system processes [G12] | | | | |
2015-003296-30: Efficacy of steroid and nonsteroidal anti-inflammatory eye drops after uncomplicated cataract surgery Anti-inflammatorisen lääkityksen valinta kaihileikkauksen jälkeen |
|
|
| Ongoing | 4 | 300 | Europe | NEVANAC, PRED FORTE, Eye drops, suspension, Nevanac, PRED FORTE | Raimo Tuuminen, University of Helsinki | Cataract senilis Vanhuuden tumakaihi, Cataract Kaihi, Diseases [C] - Eye Diseases [C11] | | | | |
2009-012985-29: Kortisondroppar, dexametason 0,1 %, jämfört med kortisondroppar i kombination med nepafenac 0.1% som behandling vid gråstarrskirurgi. En prospektiv, randomiserad, dubbel - maskerad studie |
|
|
| Ongoing | 4 | 160 | Europe | Nevanac, Isopto-Maxidex, Nevanac, Isopto-Maxidex | SU/Mölndal Sjukhus | Det vetenskapliga syftet med denna studie är att undersöka huruvida kombinationsbehandlingen med det nyintroducerade Nevanac® och standardterapi (dvs. enbart Isopto-Maxidex®) kan förebygga risken för subklinisk svullnad i gula fläcken jämfört med standardterapi enbart. | | | | |
2009-017031-18: Treatment of Cystoid Macular Edema following cataract surgery. A randomized, double-masked, placebo-controlled, clinical trial. |
|
|
| Ongoing | 4 | 120 | Europe | nepafenac, presnisolone-21-acetate, nepafenac, presnisolone-21-acetate, | Rotterdam Eye Hospital | cystoid macular edema | | | | |
2015-005313-79: Non-steroidal anti-inflammatory (NSAID) medication in cataract surgery Kaihileikkauksen non-steroidaalinen anti-inflammatorinen (NSAID) lääkitys |
|
|
| Ongoing | 4 | 100 | Europe | Dicloabak, Nevanac 1mg/ml, Eye drops, solution, Eye drops, suspension, Dicloabak, Nevanac | Raimo Tuuminen, University of Helsinki | Cataract senilis Vanhuuden tumakaihi, Cataract Kaihi, Diseases [C] - Eye Diseases [C11] | | | | |
2016-004784-40: Anti-inflammatory medication in cataract surgery of pseudoexfoliation eyes |
|
|
| Ongoing | 4 | 150 | Europe | Nevanac 1mg/ml, Pred Forte 10mg/ml, S01GX09, Ear drops, suspension, Eye drops, suspension, Nevanac 1mg/ml, Pred Forte 10mg/ml | Raimo Tuuminen, University of Helsinki | Cataract senilis, Cataract, Diseases [C] - Eye Diseases [C11] | | | | |
| Recruiting | 4 | 500 | Europe | Nepafenac Ophthalmic, Dexamethasone Ophthalmic | Oslo University Hospital | Cataract Surgery | 08/23 | 12/23 | | |
| Recruiting | 4 | 300 | Europe | Nepafenac Ophthalmic, Dexamethasone Ophthalmic | Oslo University Hospital | Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) | 06/24 | 10/26 | | |
NCT04843839: CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops |
|
|
| Recruiting | 2 | 30 | RoW | Nepafenac 0.1% Oph Susp, Amplinak, Refresh Tears 0.5% Lubricant Eye Drops, Carboxy-methylcellulose sodium lubricant eye drops 0.5%w/v | L.V. Prasad Eye Institute, Allergan | Congenital Hereditary Endothelial Dystrophy of Cornea | 12/22 | 12/22 | | |
CSCR, NCT05847049: Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy |
|
|
| Completed | N/A | 16 | RoW | Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy | Dar El Oyoun Hospital | Central Serous Chorioretinopathy | 03/23 | 04/23 | | |
NCT05542381: The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain |
|
|
| Recruiting | N/A | 72 | US | Loteprednol Etabonate Ophthalmic Gel [Lotemax], Refresh Lubricant Eye Drops [Artificial Tears], Refresh | Virginia Polytechnic Institute and State University, Vistar Eye Center | Age-Related Macular Degeneration | 05/25 | 06/25 | | |